DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

03880 MEDTIDE

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Xu Qi (42.01%)
Li Xiangli (25.36%)
Hangzhou Haibang Fenghua Investment Management Co., Ltd. (6.69%)
Lanxi Puhua Shuoyang Xiaxing Venture Investment Partnership (Limited Partnership) (6.44%)		 Sector Health Care & Biotechnology
Web Site http://www.medtideinc.com Tel (86 517) 8673-7118
Email ir@medtideinc.com Fax N/A
Related Equities N/A
Principal Activities The principal activity is to provide prominent contract research and development manufacturing organization (CRDMO) services that specializes in synthetic peptide production.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top